John Lee

Biography

John Lee joined Decibel in September 2016 as senior vice president of pharmaceutical development, and brings over 20 years of R&D, operational and leadership experience in the biotechnology industry. Prior to Decibel, he served as senior vice president of pharmaceutical development at Infinity Pharmaceuticals. Over the course of his 15 years at Infinity, John held roles of increasing responsibility and leadership. Most recently, he was responsible for chemistry, manufacturing and control (CMC), analytical sciences, formulation sciences, and clinical supply and distribution for the company’s drug candidates across all phases of global clinical development, as well as co-chair of Infinity’s operational leadership team. Prior to Infinity, John was a new product manager at Corning Life Science where he was responsible for developing new life science products from Corning research and technologies. Before Corning, John was an early member of Millennium Pharmaceuticals and played a key role in the successful positional cloning of the mouse obesity gene tubby, before taking on the role of project lead for an ovarian cancer diagnostic program. Prior to Millennium, John worked in the developmental chronobiology lab of Steven Reppert at Massachusetts General Hospital, where he focused on cloning G-protein coupled receptors and circadian biology. John received his bachelor of science in materials science and engineering from the Massachusetts Institute of Technology. 

Research Interest

 His research interest inPharmaceutical Development